GlassScriptPhysician profile
Ralph M Zagha
NPI 1063450773
$4,074.09
in general payments reported to CMS, 2019-2025
43 companies · $589 in 2025
The $589 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $341 · 2021: $640 · 2022: $486 · 2023: $567 · 2024: $872 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $477.71 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Rochester Medical Corporation | $441.16 | 2019-2021 | |
| Janssen Biotech, INC. | $317.42 | 2020-2025 | Erleada, Akeega |
| Myriad Genetic Laboratories, INC. | $301.35 | 2023-2025 | Prolaris |
| Astellas Pharma US INC | $166.49 | 2020-2023 | Myrbetriq |
| Verity Pharmaceuticals INC. | $163.76 | 2021-2024 | Tlando, Trelstar |
| Endo Pharmaceuticals INC. | $161.39 | 2019-2023 | Xiaflex |
| Boston Scientific Corporation | $154.49 | 2023-2024 | Rezum Generator, Lithovue |
| Coloplast Corp | $140.36 | 2020-2025 | Speedicath |
| Allergan, INC. | $135.67 | 2019-2021 | |
| Amgen INC. | $133.58 | 2022-2025 | Otezla, Otezla |
| Terumo Medical Corporation | $132.42 | 2022 | |
| Endo USA, INC. | $123.33 | 2025 | Xiaflex |
| Ethicon US, LLC | $113.64 | 2019 | |
| Olympus America INC. | $110.92 | 2019-2024 | Bovie, Olympus |
Show all 40 companies
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Zagha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.